THE CARDIOSELECTIVE BETA-BLOCKER TALINOLOL IN CLINICAL USE IN HYPERTENSIVE PATIENTS

Authors
VONFALLOIS J MORL H KRONIG B
Citation
J. Vonfallois et al., THE CARDIOSELECTIVE BETA-BLOCKER TALINOLOL IN CLINICAL USE IN HYPERTENSIVE PATIENTS, Perfusion, 10(8), 1997, pp. 256
Citations number
16
Categorie Soggetti
Peripheal Vascular Diseas
Journal title
Perfusion → ACNP
ISSN journal
09350020
Volume
10
Issue
8
Year of publication
1997
Database
ISI
SICI code
0935-0020(1997)10:8<256:TCBTIC>2.0.ZU;2-1
Abstract
The antihypertensive therapy with the cardioselective beta-receptor an tagonist talinolol is effective and safe in patients with mild to mode rate hypertension, An increase of the talinolol dosage was not associa ted with an increase of side effects or study interruptions, In more t han 90% of the patients a one daily dose of 100 mg talinolol was suffi cient. The profitable metabolic characteristics of talinolol especiall y concerning the lipid metabolism, are to be pointed out advantageous regarding the development of coronary heart disease.